Anti-β2GPI/β2GPI stimulates activation of THP-1 cells through TLR4/MD-2/MyD88 and NF-κB signaling pathways

Thrombosis Research

Volumn 132, Issue 6, 2013, Pages 742-749

  Zhou, Hong ^a,b   Sheng, Liangju ^b   Wang, Haibo ^c   Xie, Hongxiang ^b   Mu, Yuan ^b   Wang, Ting ^b   Yan, Jinchuan ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

^c AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

2 glycoprotein I; Anti 2 glycoprotein I antibodies; NF B; proinflammatory molecules; THP 1 cells; TLR4 MD 2 MyD88

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN MD 2; PYRROLIDINE DITHIOCARBAMATE; RESATORVID; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; LY96 PROTEIN, HUMAN; MYD88 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; Β(2)-GLYCOPROTEIN I; ANTI-Β(2)-GLYCOPROTEIN I ANTIBODIES; ANTIGEN ANTIBODY COMPLEX; CELL LINE; IMMUNOLOGY; METABOLISM; NF-ΚB; PHOSPHORYLATION; PROINFLAMMATORY MOLECULES; THP-1 CELLS; TLR4/MD-2/MYD88;

Β(2)-GLYCOPROTEIN I; ANTI-Β(2)-GLYCOPROTEIN I ANTIBODIES; NF-ΚB; PROINFLAMMATORY MOLECULES; THP-1 CELLS; TLR4/MD-2/MYD88;

ANTIGEN-ANTIBODY COMPLEX; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CELL LINE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LYMPHOCYTE ANTIGEN 96; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84889887563     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.09.039     Document Type: Article

References (40)

1. S. Miyakis, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, and R. Cervera International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 306
2. R. Willis, E.N. Harris, and S.S. Pierangeli Pathogenesis of the Antiphospholipid Syndrome Semin Thromb Hemost 38 2012 305 321
3. D. Tanne, A. Katzav, O. Beilin, N.C. Grigoriadis, M. Blank, and C.G. Pick Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome Neurobiol Dis 30 2008 56 64
4. S.V. Seshan, C.W. Franzke, P. Redecha, M. Monestier, N. Mackman, and G. Girardi Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies Blood 114 2009 1675 1683
5. J. Nojima, Y. Masuda, Y. Iwatani, E. Suehisa, Y. Futsukaichi, and H. Kuratsune Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients Biochem Biophys Res Commun 365 2008 195 200
6. M.J. Mulla, J.J. Brosens, L.W. Chamley, I. Giles, C. Pericleous, and A. Rahman Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway Am J Reprod Immunol 62 2009 96 111
7. A.A. Mehdi, I. Uthman, and M. Khamashta Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future Eur J Clin Invest 40 2010 451 464
8. J. Zhang, and K.R. McCrae Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies Blood 105 2005 1964 1969
9. H. Zhou, S. Ling, Y. Yu, T. Wang, and H. Hu Involvement of annexin A2 in anti-beta2GPI/beta2GPI-induced tissue factor expression on monocytes Cell Res 17 2007 737 739
10. Z. Romay-Penabad, M.G. Montiel-Manzano, T. Shilagard, E. Papalardo, G. Vargas, and A.B. Deora Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo Blood 114 2009 3074 3083
11. Y. Shoenfeld, M. Blank, R. Cervera, J. Font, E. Raschi, and P.L. Meroni Infectious origin of the antiphospholipid syndrome Ann Rheum Dis 65 2006 2 6
12. M. Blank, R.A. Asherson, R. Cervera, and Y. Shoenfeld Antiphospholipid syndrome infectious origin J Clin Immunol 24 2004 12 23
13. J. Hurst, M. Lorenz, N. Prinz, and P. von Landenberg The roll of Toll-like receptors in the antiphospholipid syndrome Curr Rheumatol Rep 12 2010 58 63
14. R. Ostuni, I. Zanoni, and F. Granucci Deciphering the complexity of Toll-like receptor signaling Cell Mol Life Sci 67 2010 4109 4134
15. S.S. Pierangeli, M.E. Vega-Ostertag, E. Raschi, X. Liu, Z. Romay-Penabad, and V. De Micheli Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies Ann Rheum Dis 66 2007 1327 1333
16. M. Sorice, A. Longo, A. Capozzi, T. Garofalo, R. Misasi, and C. Alessandri Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts Arthritis Rheum 56 2007 2687 2697
17. M. Kobayashi, S. Saitoh, N. Tanimura, K. Takahashi, K. Kawasaki, and M. Nishijima Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering J Immunol 176 2006 6211 6218
18. N. Resman, J. Vasl, A. Oblak, P. Pristovsek, T.L. Gioannini, and J.P. Weiss Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin J Biol Chem 284 2009 15052 15060
19. Y. Gao, X. Fang, Y. Tong, Y. Liu, and B. Zhang TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice Biomed Pharmacother 63 2009 442 450
20. A.F. McGettrick, and L.A. O'Neill Regulators of TLR4 signaling by endotoxins Subcell Biochem 53 2010 153 171
21. H. Zhou, A.S. Wolberg, and R.A. Roubey Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep Blood 104 2004 2353 2358
22. H. Zhou, H. Wang, N. Li, Y. Yu, H. Huang, and Y. Yan Annexin A2 mediates anti-beta 2 GPI/beta 2 GPI-induced tissue factor expression on monocytes Int J Mol Med 24 2009 557 562
23. H. Zhou, Y. Yan, G. Xu, B. Zhou, H. Wen, and D. Guo Toll-like receptor (TLR)-4 mediates anti-beta2GPI/beta2GPI-induced tissue factor expression in THP-1 cells Clin Exp Immunol 163 2011 189 198
24. H. Xie, H. Zhou, H. Wang, D. Chen, L. Xia, and T. Wang Anti-beta(2)GPI/beta(2)GPI induced TF and TNF-alpha expression in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling pathways Mol Immunol 53 2013 246 254
25. J. Boles, and N. Mackman Role of tissue factor in thrombosis in antiphospholipid antibody syndrome Lupus 19 2010 370 378
26. J. Swadzba, T. Iwaniec, and J. Musial Increased level of tumor necrosis factor-alpha in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state Rheumatol Int 31 2011 307 313
27. C.T. Esmon Crosstalk between inflammation and thrombosis Maturitas 61 2008 122 131
28. P.K. Wong, I.K. Campbell, P.J. Egan, M. Ernst, and I.P. Wicks The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover Arthritis Rheum 48 2003 1177 1189
29. C. Le Quement, I. Guenon, J.Y. Gillon, V. Lagente, and E. Boichot MMP-12 induces IL-8/CXCL8 secretion through EGFR and ERK1/2 activation in epithelial cells Am J Physiol Lung Cell Mol Physiol 294 2008 L1076 L1084
30. K.L. Allen, F.V. Fonseca, V. Betapudi, B. Willard, J. Zhang, and K.R. McCrae A novel pathway for human endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies Blood 119 2012 884 893
31. S. Vallabhapurapu, and M. Karin Regulation and function of NF-kappaB transcription factors in the immune system Annu Rev Immunol 27 2009 693 733
32. T. Colasanti, C. Alessandri, A. Capozzi, M. Sorice, F. Delunardo, and A. Longo Autoantibodies specific to a peptide of beta2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes Blood 120 2012 3360 3370
33. A. Lambrianides, C.J. Carroll, S.S. Pierangeli, C. Pericleous, W. Branch, and J. Rice Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways J Immunol 184 2010 6622 6628
34. K. Takashima, N. Matsunaga, M. Yoshimatsu, K. Hazeki, T. Kaisho, and M. Uekata Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model Br J Pharmacol 157 2009 1250 1262
35. N. Matsunaga, N. Tsuchimori, T. Matsumoto, and M. Ii TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules Mol Pharmacol 79 2011 34 41
36. J.E. Alard, F. Gaillard, C. Daridon, Y. Shoenfeld, C. Jamin, and P. Youinou TLR2 is one of the endothelial receptors for beta 2-glycoprotein I J Immunol 185 2010 1550 1557
37. K. Poulton, A. Rahman, and I. Giles Examining how antiphospholipid antibodies activate intracellular signaling pathways: a systematic review Semin Arthritis Rheum 41 2012 720 736
38. Z. Romay-Penabad, R. Aguilar-Valenzuela, R.T. Urbanus, R.H. Derksen, M.T. Pennings, and E. Papalardo Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome Blood 117 2011 1408 1414
39. E. Raschi, M.O. Borghi, C. Grossi, V. Broggini, S. Pierangeli, and P.L. Meroni Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome Lupus 17 2008 937 942
40. Y. Doring, J. Hurst, M. Lorenz, N. Prinz, N. Clemens, and M.D. Drechsler Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8 Immunobiology 215 2010 230 241